Eisler Capital (UK)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$43.1M Buy
265,980
+13,141
+5% +$2.09M 0.2% 107
2024
Q2
$37M Buy
252,839
+53,003
+27% +$7.88M 0.24% 108
2024
Q1
$31.6M Buy
199,836
+81,262
+69% +$12.9M 0.27% 95
2023
Q4
$18.6M Buy
118,574
+61,435
+108% +$9.42M 0.14% 139
2023
Q3
$8.9M Buy
57,139
+53,139
+1,328% +$8.77M 0.06% 223
2023
Q2
$662K Buy
+4,000
New +$646K ﹤0.01% 322

Other funds holding JNJ

Eisler Capital (UK)'s JNJ Position: Q3 2024 in Review

Eisler Capital (UK) reduced its Johnson & Johnson (JNJ) stake by 73% in Q3 2024, selling an estimated $5.52M and leaving 13,063 shares worth $2.12M. The position accounts for 0.01% of the portfolio, ranked #437.

Eisler Capital (UK) first reported a position in JNJ in Q3 2021 and has held it in 4 quarters since. The position peaked at $6.97M in Q2 2024. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Eisler Capital (UK) held 13,063 shares of Johnson & Johnson worth $2.12M as of Q3 2024.
  • Eisler Capital (UK) sold 34,658 Johnson & Johnson shares in Q3 2024, an estimated $5.52M.
  • Johnson & Johnson made up 0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #437 holding.
  • Eisler Capital (UK) first reported a position in Johnson & Johnson in Q3 2021 and has held it in 4 quarters since.
  • Eisler Capital (UK)'s Johnson & Johnson position peaked at $6.97M in Q2 2024.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.